Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499

M. R. Smith, F. Hong, H. Li, L. I. Gordon, R. D. Gascoyne, E. M. Paietta, R. H. Advani, A. Forero-Torres, S. J. Horning, B. S. Kahl

Research output: Contribution to journal › Letter › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499'. Together they form a unique fingerprint.